Carlos Alberto
Flores Infante
External Researcher
University of British Columbia
Vancouver, CanadáPublications in collaboration with researchers from University of British Columbia (8)
2022
-
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
Nature Immunology, Vol. 23, Núm. 2, pp. 159-164
2020
-
Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation
Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 621-628
-
Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization (The Pharmacogenomics Journal, (2020), 20, 5, (621-628), 10.1038/s41397-019-0140-y)
Pharmacogenomics Journal
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
-
Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis
American Journal of Respiratory and Critical Care Medicine, Vol. 201, Núm. 5, pp. 564-574
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
2017
-
Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium
Pharmacogenomics, Vol. 18, Núm. 10, pp. 931-943
-
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
The Lancet Respiratory Medicine, Vol. 5, Núm. 11, pp. 869-880